U 50488H
Alternative Names: U 50488Latest Information Update: 01 Mar 2004
At a glance
- Originator Pharmacia Corporation
- Developer Nonindustrial source; Pharmacia Corporation
- Class Antiarrhythmics; Antiepileptic drugs; Antirheumatics; Antiulcers; Neuroprotectants; Opioid analgesics
- Mechanism of Action Opioid kappa receptor agonists; Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Arrhythmias; Pain; Peptic ulcer; Rheumatoid arthritis
Most Recent Events
- 01 Mar 2004 Discontinued - Preclinical for Anxiety disorders (unspecified route)
- 01 Mar 2004 Discontinued - Preclinical for Arrhythmias in Australia (unspecified route)
- 01 Mar 2004 Discontinued - Preclinical for Arrhythmias in Canada (unspecified route)